Beckman Coulter Life Sciences

The human CD90 antigen (also known as Thy-1) is the smallest (18 kDa) member of the immunoglobulin gene superfamily (IgSF). It is a highly glycosylated molecule with a glycosyl-phosphatidylinositol (GPI) anchor consisting of a single IgSF variable domain.

The human CD90 antigen (also known as Thy-1) is the smallest (18 kDa) member of the immunoglobulin gene superfamily (IgSF). It is a highly glycosylated molecule with a glycosyl-phosphatidylinositol (GPI) anchor consisting of a single IgSF variable domain.

The human CD90 antigen (also known as Thy-1) is the smallest (18 kDa) member of the immunoglobulin gene superfamily (IgSF). It is a highly glycosylated molecule with a glycosyl-phosphatidylinositol (GPI) anchor consisting of a single IgSF variable domain.

The human CD90 antigen (also known as Thy-1) is the smallest (18 kDa) member of the immunoglobulin gene superfamily (IgSF). It is a highly glycosylated molecule with a glycosyl-phosphatidylinositol (GPI) anchor consisting of a single IgSF variable domain.

CD94 is a type II transmembrane glycoprotein of 30 kDa, belonging to the Ca++-dependent (C-type) lectin family.

CD94 is a type II transmembrane glycoprotein of 30 kDa, belonging to the Ca++-dependent (C-type) lectin family.

CD94 is a type II transmembrane glycoprotein of 30 kDa, belonging to the Ca++-dependent (C-type) lectin family.

The CD95 (Fas or APO-1) antigen is a 40-50 kDa transmembrane glycoprotein. It belongs to the Tumor Necrosis Factor (TNF) superfamily and contains three cysteine-rich repeats. This cell surface molecule mediates apoptosis (programmed cell death).

The CD95 (Fas or APO-1) antigen is a 40-50 kDa transmembrane glycoprotein. It belongs to the Tumor Necrosis Factor (TNF) superfamily and contains three cysteine-rich repeats. This cell surface molecule mediates apoptosis (programmed cell death).

CYTO-COMP Cell Kit is a preparation of lyophilized human lymphocytes and reconstitution buffer used in conjunction with the CYTO-COMP Reagent Kit to establish and monitor color compensation settings for multicolor analysis.

CYTO-TROL Control Cells are used to assess the activity of monoclonal antibodies by flow cytometry. They are a lyophilized preparation of human lymphocytes that exhibit surface antigens detectable with monoclonal antibodies.

Rask og effektiv rensing av Sanger-fargestoff-terminatorer CleanSEQ benytter paramagnetiske kuler i SPRI-teknologi (Solid Phase Reversible Immobilization) for å fjerne fargestoff-terminatorer og rester fra sekvenseringsreaksjoner – uten behov for sentrifugering eller filtrering

The ClearLLab 10C Panels are intended for in vitro diagnostic use for qualitative identification of cell populations by multiparameter immunophenotyping on the Navios and Navios EX flow cytometers. The ClearLLab 10C B Cell Tube provides multiparameter, qualitative results for the following surface antigens: Kappa, Lambda, CD10, CD5, CD200, CD34, CD38, CD20, CD19, CD45.

The ClearLLab 10C Panels are intended for in vitro diagnostic use for qualitative identification of cell populations by multiparameter immunophenotyping on the Navios and Navios EX flow cytometers. The ClearLLab 10C M1 Cell Tube provides multiparameter, qualitative results for the following surface antigens: CD16, CD7, CD10, CD13, CD64, CD34, CD14, HLA-DR, CD11b, CD45

The ClearLLab 10C Panels are intended for in vitro diagnostic use for qualitative identification of cell populations by multiparameter immunophenotyping on the Navios and Navios EX flow cytometers. The ClearLLab 10C M2 Cell Tube provides multiparameter, qualitative results for the following surface antigens: CD15, CD123, CD117, CD13, CD33, CD34, CD38, HLA-DR, CD19, CD45

The ClearLLab 10C Panels are intended for in vitro diagnostic use for qualitative identification of cell populations by multiparameter immunophenotyping on the Navios and Navios EX flow cytometers. ClearLLab 10C T Cell Tuber provides multiparameter, qualitative results for the following surface antigens: TCRγδ, CD4, CD2, CD56, CD5, CD34, CD7, CD8, CD3, CD45

The ClearLLab LS (Lymphoid Screen) reagent is intended for in vitro diagnostic use as a screening panel for identification of various hematolymphoid cell populations by immunophenotyping on an Navios flow cytometer. The antigen specificity of the CD45, CD3, CD4, CD8, CD56 and CD5 monoclonal antibodies has been previously established by the First (CD4, CD8 and CD3), Third (CD5 and CD45),and Fourth (CD56) International Workshop for Leukocyte Typing. The antigen specificity of the CD20, CD19, CD10 and CD34 monoclonal antibodies has been previously established by the Human Leukocyte Differentiation Antigen Workshops. The application of Kappa and Lambda light chain analysis for immunophenotyping B lymphopoetic malignancies has been previously described in the flow cytometric immunophenotyping for hematologic neoplasms.

The ClearLLab Compensation kit consists of ten single-color fluorescent reagent tubes comprised of one monoclonal antibody : CD3 or CD4 or CD8.

ClearLLab Compensation Beads are to be used in conjunction with the ClearLLab Compensation Kit to establish compensation settings on the Navios and Navios EX Flow Cytometer(s) prior to multicolor analysis with the ClearLLab 10C Panels.

ClearLLab Control Cells Normal and ClearLLab Control Cells Abnormal are stabilized preparations of assayed, lysable whole blood intended as process controls for the verification of the ClearLLab 10C Panels on the Navios and Navios EX flow cytometers.

ClearLLab Control Cells Normal and ClearLLab Control Cells Abnormal are stabilized preparations of assayed, lysable whole blood intended as process controls for the verification of the ClearLLab 10C Panels on the Navios and Navios EX flow cytometers.

CD370, also called CLEC9A is a group V C-type lectin receptor (CTLR) comprised of a single extracellular C-type lectin domain (CTLD) connected to the transmembrane domain by a stalk region and an intracellular cytoplasmic tail.